Search Results 271-280 of 16918 for Acyclovir

  1. Darunavir (oral route) - Side effects & dosage - Mayo Clinic

    Darunavir is used in combination with ritonavir (Norvir®) and other medicines for the treatment of the infection caused by the human immunodeficiency virus (HIV) ...

  2. aspirin Archives - Mayo Clinic News Network

  3. Crofelemer (oral route) - Mayo Clinic

    Crofelemer is used to relieve symptoms of non-infectious diarrhea in patients with human immunodeficiency virus (HIV) or acquired immune deficiency syndrome ( ...

  4. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  5. Oncology (Medical) - Clinical trials

    The purpose of this study is to identify the side effects and best dose of abemaciclib when given together with olaparib in treating patients with ovarian ...

  6. Helping Children Grieve: For Teens - Mayo Clinic

    I'm Paula Hampel and I help young people after a loved one has died. If someone you love has died, you're really hurting. This may be one of the hardest things ...

  7. Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism - Mayo Clinic

    Inclusion Criteria: -Age 18-80 years, inclusive -Objectively confirmed acute PE, based on computed tomography pulmonary angiography (CTPA) showing a filling ...

  8. Etranacogene dezaparvovec-drlb (intravenous route) - Side effects & uses - Mayo Clinic

    Etranacogene dezaparvovec-drlb injection is used to treat hemophilia B (congenital Factor IX deficiency) in patients who are using Factor IX treatment, have ...

  9. Copanlisib (intravenous route) - Side effects & uses - Mayo Clinic

    Copanlisib injection is used to treat follicular lymphoma that has come back after treatment with at least two previous medicines that did not work well. This ...

  10. A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor - Mayo Clinic

    About this study. This is a Phase II, open-label, two strata, multicenter, prospective study of plerixafor-mobilized HLA-identical sibling allografts in ...